InvestorBrandNetwork (IBN) Content Platform

Nemaura (NASDAQ: NMRD) is a medical technology company focused on developing and commercializing noninvasive wearable diagnostic devices and supporting personalized lifestyle and weight reduction programs. The company today announced that its CEO Dr. Faz Chowdhury will present a corporate overview at the Sidoti & Co. Micro Cap Virtual Conference being held on Jan. 18 -19, 2023. Dr. Chowdhury is scheduled to present at 9:15 a.m. ET on Jan. 19 and will will be available for one-on-one investor meetings throughout the conference. Interested parties should visit https://ibn.fm/hhaBZ and https://ibn.fm/gtc7k to register for the event and access the webinar.

To view the full press release, visit https://ibn.fm/o12br

About Nemaura Medical Inc.

Nemaura is a medical technology company developing and commercializing noninvasive wearable diagnostic devices. The company is currently commercializing sugarBEAT(R) and proBEAT(TM). sugarBEAT, a CE mark approved Class IIb medical device, is a noninvasive and flexible continuous glucose monitor (“CGM”) providing actionable insights derived from real time glucose measurements and daily glucose trend data, which may help people with diabetes and prediabetes to better manage, reverse and prevent the onset of diabetes. Nemaura has submitted a PMA (Premarket Approval Application) for sugarBEAT to the U.S. FDA. proBEAT combines noninvasive glucose data processed using artificial intelligence and a digital health care subscription service that has been launched in the U.S. as a general wellness product as part of its BEAT(R) diabetes program that is currently undergoing pilot studies. The company sits at the intersection of the global type 2 diabetes market that is expected to reach nearly $59 billion by 2025, the $50+ billion pre-diabetic market, and the wearable health-tech sector for weight loss and wellness applications that is estimated to reach $60 billion by 2023. For more information, visit the company’s website at www.NemauraMedical.com.

NOTE TO INVESTORS: The latest news and updates relating to NMRD are available in the company’s newsroom at https://ibn.fm/NMRD

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

• Report notes that the global direct-selling establishments market is expected to close the year out at a compound annual growth rate (“CAGR”) of 3.8%
• The need for additional income opportunities has been a driving factor in the direct-selling establishments market
• SHRG is committed to stay ahead of marketplace trends, fulfill needs, create sustainable enterprise growth and consistently increase shareholder value

In a market forecast to grow an estimated $20 billion this year alone (https://ibn.fm/tijsB), Sharing Services Global (OTCQB: SHRG) distinguishes itself in the direct-sales space by focusing on a mission to increase shareholder value by adhering to standards of excellence that optimize the value of the people involved, supply chain, and channel of distribution, achieving optimal customer satisfaction through every subsidiary and partnership interest (https://ibn.fm/enZPD).

“The global direct-selling establishments market is expected to grow from $449.79 billion in 2021 to $466.73 billion in 2022 at a compound annual growth rate (‘CAGR’) of 3.8%,” reported a recent ResarchandMarketing.com release. “The market is expected to grow to $510.39 billion in 2026 at…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to SHRG are available in the company’s newsroom at http://ibn.fm/SHRG

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

CubCrafters is the leading designer and manufacturer of light-sport, experimental and Part 23 certified backcountry aircraft. “CubCrafters President and CEO Patrick Horgan recently provided an update, announcing in a Bell2Bell podcast that the U.S. Securities and Exchange Commission (‘SEC’) has qualified the company’s Reg A+ filing, clearing the way for investors to come onboard… Horgan said that the company has booked orders already awaiting fulfillment for the next two years of CubCrafters’ production schedule, and a large part of the reason for turning to public funding is to help the company grow sufficiently that it can reduce customers’ wait times, and provide better support for the growing fleet of aircraft worldwide,” a recent article reads. “We’re the preeminent builder of adventure airplanes. We build advanced versions of the Super Cub using current-day technology. It’s a utilitarian-type airplane that can access backcountry areas without the need for runways,” Horgan is quoted as saying. “[It’s] high performance with the latest technology, engines and avionics. It’s an airplane that can be used commercially as well as just for a lot of fun. It’s a fun-flying airplane that really just brings a unique perspective to using aviation to access our world.”

To view the full article, visit https://ibn.fm/4A3wF

About CubCrafters Inc.

Founded in 1980 by Jim Richmond, CubCrafters’ roots are in the 80+ year history of classic grassroots aviation, but the company’s products and services are innovative and completely modern. CubCrafters designs and manufactures experimental, LSA, and Part 23 certified aircraft. The Carbon Cub family of aircraft redefined expectations for the backcountry flying experience with innovative design, modern materials, powerful engines, and breathtaking performance. The company’s flagship XCub aircraft is offered in both nosewheel and tailwheel configurations, and substantially expands the mission profile of sport utility aircraft with higher speed, longer range and larger payload. The key to CubCrafters’ success is its ability to create unique value in the experience of personal adventure aviation. For more information about the company, visit www.CubCrafters.com.

NOTE TO INVESTORS: The latest news and updates relating to CubCrafters are available in the company’s newsroom at https://ibn.fm/CUB

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Advisors Mortgage Group, based in Ocean Township, New Jersey, has announced that its weekly show that provides information about the mortgage and real estate markets will be traveling this year. The Jon & Jim Show is scheduled for live appearances beginning this year, with the first show slated for Jan. 17, 2023, at the Bristol, Pennsylvania, Advisors Mortgage branch. The show features hosts Jon Iacono, a business development manager/market analyst, and Jim Ragan, a renovation department manager. The pair started the show in 2019, with each segment featuring in-depth discussions. The weekly show provides an extensive analysis of the current market, including home sales data, mortgage-backed security charting, and analysis along with mortgage rate forecasting, updates on the Federal Reserve, sales motivation, and more. A former mortgage broker, Iacono also worked at Mortgage Market Guide and then MBS Highway, which is a cutting-edge digital platform that helps mortgage professionals interpret and communicate the mortgage rate and real estate markets. Ragan has designed and managed sales and operations for FHA 203(k) and Fannie Mae HomeStyle products for three decades. “My goal with the Jon & Jim Show is to help our listeners understand the mortgage and housing markets without all of the smoke and mirrors created by various other sources,” said Jon & Jim Show host Jon Iacono in the press release. “We tell it how it is and take a deep dive into the data and reports every week. Jim and I want to help loan officers become trusted advisors who build trust through articulating knowledge and by connecting the dots of many market-moving reports and bond market volatility.”

To view the full press release, visit https://ibn.fm/cPfoQ

About Advisors Mortgage Group LLC

With big dreams and even bigger determination, Advisors Mortgage was founded in October 1999 by a single loan officer in a 400-square-foot office in Shrewsbury, New Jersey. In the years since its formation, Advisors has grown to serve not only the greater New Jersey area but also a vast portion of the United States. With branch offices up and down the East Coast and its corporate office in Ocean Township, New Jersey, Advisors Mortgage has established itself as a pillar of excellence in the mortgage industry. The company’s immense experience is its greatest asset and is the foundation of the success of the company and every Advisors branch and loan officer. In 2005, Advisors Mortgage Group was designated by the Federal Housing Authority as a Full Eagle FHA Underwriter. As a Full Eagle, Advisors has been able to expand its loan volume by approving loans that a majority of the competition could not dream of. The company has built a platform for a seamless and stress-free mortgage process for customers, and all branches share the same mission. Advisors understands that success cannot be attained without teamwork and communication, two of the company’s most important strengths. For more information about the company, visit www.AdvisorsMortgage.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Nextech (CSE: NTAR) (OTCQX: NEXCF) (FSE: EP2), a metaverse company and leading provider of augmented reality (“AR”) experience technologies and 3D model services, today announced a patent update covering its breakthrough artificial intelligence (“AI”) technology 3D model creation. The company also reported that this proprietary AI-based 3D model creation using through composition of deformable parts is now covered under U.S. patent application number 17/874,992. “Today we are leveraging the game-changing power of generative AI, which we believe gives us a major competitive advantage in the 3D model market. With generative AI we are creating an increasingly wider exponentially growing moat: the more models we make, the larger that part library gets, and the easier it gets to make new 3D models,” said Evan Gappelberg, CEO of Nextech. “I believe that we are at the point where the value of Nextech goes up with each new 3D model we make, creating a virtuous cycle of growth and value. 2023 is going to be the year of AI. We have already announced multimillion-dollar enterprise contacts and more are expected in 2023. With our breakthrough AI that we are continuously developing, we are becoming the global go-to 3D model supplier for ecommerce. With hundreds of millions of 3D models needing to be made, we have been heavily investing in AI, which is now paying dividends. Our proprietary breakthrough AI perfectly positions us to take full advantage of the multibillion-dollar decade-long 3D model megatrend!”

To view the full press release, visit https://ibn.fm/yFIiA

About Nextech AR Solutions Corp.

Nextech is a diversified AR, AI technology company that leverages proprietary artificial intelligence (“AI”) to create 3D experiences for the metaverse. Its main businesses are creating 3D WebAR photorealistic models for the prime ecommerce marketplace as well as many other online retailers. The company develops or acquires what it believes are disruptive technologies and, once commercialized, spins them out as stand-alone public companies issuing a stock dividend to shareholders while retaining a significant ownership stake in the public spin-out. For more information about the company, visit www.NextechAR.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today provided a progress update on its sponsored research study with the University of California, San Francisco (“UCSF”). The study, which examines psilocybin’s effect on inflammatory activity in humans, evaluates three populations of patients suffering from Parkinson’s disease, bipolar and chronic pain. “The UCSF research team is making progress on the clinical trial. The data gathered from these studies could uncover the role of inflammatory activity on such conditions as Parkinson’s, bipolar disorder and chronic pain,” said Eric Weisblum, chief executive officer of Silo Pharma. “Utilizing psilocybin in this study in a regimented dosing pattern, we hope to gain significant data both in mechanism of action and potential biomarker for personalization of psilocybin therapy. The targeted patient populations from the study could provide support for the development and use of psilocybin as a therapeutic coupled with our novel homing peptides and topical technology.”

To view the full press release, visit https://ibn.fm/8sNNu

About Silo Pharma Inc.

Silo Pharma is a development-stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as PTSD, Alzheimer’s and other rare neurological disorders. Silo’s mission is to identify assets to license and fund the research, which it believes will be transformative to the well-being of patients and the health care industry. For more information about the company, visit www.SiloPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to SILO are available in the company’s newsroom at https://ibn.fm/SILO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

CISO Global (NASDAQ: CISO), an industry leader as a managed cybersecurity and compliance provider formally known as Cerberus Sentinel, has signed a definitive agreement to acquire RAN Security, a cybersecurity company headquartered in Buenos Aires, Argentina, and with offices in Chile, Peru, Bolivia, and Paraguay. According to the agreement, RAN Security will become a wholly owned subsidiary of Cerberus Sentinel. CISO Global anticipates the transaction will be finalized later this year following customary closing conditions and applicable regulatory approvals. RAN Security offers secured managed services to organizations across South America and is part of a growing network of companies acquired by CISO Global in Latin America, including Arkavia, CUATROi and NLT. “RAN Security expands our growth strategy in Latin America and adds to our SOC/managed detection and response services,” said CISO Global CEO and founder David Jemmett in the press release. “Cybersecurity requires global capabilities to properly address the security demands of businesses and organizations. RAN Security is an excellent cultural fit with the Cerberus Sentinel family of companies.”

To view the full press release, visit https://ibn.fm/yEMvQ

About CISO Global Inc.

CISO Global is an industry leader in managed cybersecurity and a compliance provider. The company is rapidly expanding by acquiring world-class cybersecurity, secured managed services and compliance companies with top-tier talent that utilize the latest technology to create innovative solutions to protect the most demanding businesses and government organizations against continuing and emerging security threats and compliance obligations. For more information about the company, visit www.CISO.inc.

NOTE TO INVESTORS: The latest news and updates relating to CISO are available in the company’s newsroom at https://ibn.fm/CISO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Data443 (OTC: ATDS), a data security and privacy software company for “All Things Data Security,” today announced that its Data443(R) Antivirus Protection Manager(TM) has received VB100 certification. The certification is administered by Virus Bulletin, an independent organization that has tested antivirus products for more than 25 years. Joining leading organizations such as SentinelOne (NYSE: S), Fortinet (NASDAQ: FTNT), Avast Intego and Tacyon, Data443’s antivirus product is available for Microsoft Windows via desktops, laptops, virtual desktops, database engines, and Azure/AWS/GCP, along with hybrid cloud platforms and standard compute servers. “At Data443, we make every effort to help protect customers from the ever-growing cyber threat environment,” said the company’s founder and CEO Jason Remillard. “Achieving VB100 certification and besting some of the world’s largest competitors on false alarms delivers on our technical market leadership of our antivirus protection and ransomware product line. With so many antivirus products on the market, it can be difficult for consumers and businesses to determine which are truly effective at protecting against malware. VB100 certification helps to cut through the marketing hype and provides a reliable benchmark for comparing antivirus products.”

To view the full press release, visit https://ibn.fm/3U7Tf

About Data443 Risk Mitigation Inc.

Data443 Risk Mitigation (All Things Data Security(TM)) provides data security and privacy management solutions at home, in the small office and across the enterprise for the multi-cloud. Trusted by over 10,000 business customers, the company focuses on organizing the world’s data by identifying and protecting all sensitive data regardless of location, platform or format. For more information, please visit www.Data443.com.

NOTE TO INVESTORS: The latest news and updates relating to ATDS are available in the company’s newsroom at https://ibn.fm/ATDS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Amesite’s (NASDAQ: AMST) CEO Dr. Ann Marie Sastry recently sat down for a chat with Benzinga to discuss the Detroit-based company’s past year of successful partnerships and to look ahead to a promising 2023. Dr. Sastry explained how Amesite is an educational technology (“EdTech”) software-as-a-service (“SaaS”) company helping modernize educational systems via its artificial intelligence (“AI”) powered white-label eLearning services. Instead of competing with existing educational infrastructure, Amesite collaborates to update branded programs via its AI-driven platform. “We are proving our theory every day that most professional training as one segment will go online — that is the future,” said Dr. Sastry. “And that online learning has to be great in order for organizations to succeed, in order for brands to succeed, and in order for people to move ahead.”

To view the full video, visit https://ibn.fm/3rJRJ

About Amesite Inc.

Amesite is an artificial intelligence-driven platform and course designer providing online products in the United States. The company uses machine learning to offer a mass customized experience to learners. Its customers include businesses, universities and colleges, K-12 schools, and non-profit organizations. The company was incorporated in 2017 and is headquartered in Detroit, Michigan. For more information, visit https://amesite.com.

NOTE TO INVESTORS: The latest news and updates relating to AMST are available in the company’s newsroom at https://ibn.fm/AMST

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Vistagen (NASDAQ: VTGN) is a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (“CNS”) disorders. The company today announced that the last patient has completed the study protocol in its phase 2 clinical trial of PH94B for the treatment of adults experiencing adjustment disorder with anxiety (“AjDA”). “The four-week treatment protocol for our final enrolled patient is complete. This is a major milestone for our team,” said Shawn Singh, chief executive officer of Vistagen. “Along with many other mental health challenges, the prevalence of adjustment disorder is alarming due to increasing levels of health, safety, economic and social stressors that adversely impact mental health and wellbeing. Vistagen is dedicated to developing treatments to address the escalating mental health crisis. We look forward to completing data analysis for this important study over the coming months.”

To view the full press release, visit https://ibn.fm/65fkc

About VistaGen Therapeutics Inc.

Vistagen is a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other CNS disorders. The company is advancing therapeutics with the potential to be faster-acting and with fewer side effects and safety concerns than those that are currently available. Vistagen’s clinical-stage candidates are targeting multiple forms of anxiety and depression. PH94B and PH10 belong to a new class of drugs known as pherines, which are investigational neuroactive steroid nasal sprays designed with a novel rapid-onset mechanism of action that activates chemosensory neurons in the nasal passages and can impact the olfactory-amygdala neural circuits without systemic uptake or direct activity on CNS neurons in the brain. Vistagen is passionate about transforming mental health care and redefining what is possible in the treatment of anxiety and depression. For more information, visit the company’s website at www.Vistagen.com.

NOTE TO INVESTORS: The latest news and updates relating to VTGN are available in the company’s newsroom at https://ibn.fm/VTGN

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

BlockQuarry (OTC: BLQC), a Texas-based company with commercial-stage operations in the energy and infrastructure industry focusing on cryptocurrency mine hosting and self-mining in the Southeast United States, today provided an update to its shareholders. According to the announcement, the company has cancelled $5 million in debt, resulting in a 30% reduction in overall liabilities on its balance sheet. In addition, BlockQuarry was able to extend maturity dates on its remaining notes with its largest debtholder, RB Capital Partners. “I’m very excited about the substantial moves we were able to make with some of our debtholders, including our largest investor, RB Capital. These moves are a key part of our strategy to clean up our balance sheet and help maximize shareholder equity,” said Alonzo Pierce, president and chair of BlockQuarry. “Not only were we able to cancel debt, but we were also able to extend the maturity date on our remaining notes with RB Capital, taking them out of default. This is important, as it will reduce the derivative liabilities that show up on our balance sheet. The company is now in a much stronger position, and shareholder value has undoubtedly increased.”

To view the full press release, visit https://ibn.fm/GsyJq

About BlockQuarry Corp.

BlockQuarry is an energy and infrastructure company focused on cryptocurrency hosting and self-mining operations, with leased properties located within the Southeast United States. BlockQuarry also maintains a fleet of digital/cryptocurrency mining equipment and infrastructure.

NOTE TO INVESTORS: The latest news and updates relating to BLQC are available in the company’s newsroom at http://ibn.fm/BLQC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Kronos Advanced Technologies (OTC: KNOS), an innovation-driven product development company and creator of patented Kronos(R) CORE air disinfection technology inside its advanced smart air purification devices, today announced that the U.S. Food and Drug Administration (“FDA”) has recently granted 510(k) / Class II Medical Device clearance. According to the update, the FDA clearance was provided after a detailed review of the patented Model 5 device, which utilizes patented High Voltage Field air disinfection technology and is proven to eliminate 99.9% of harmful airborne particles, including allergens, bacteria, fungi, and viruses, like COVID-19. “We are proud that our manufacturer has been granted FDA clearance for the Model 5 Air Purifier, and we want to thank the FDA team for their investigation and test results review of Kronos CORE patented air disinfection technology,” said Michael Rubinov, CEO of Kronos. “We have been developing air disinfection and purification technology since 2002, and we are experts in indoor air quality. The recently approved FDA clearance of the Model 5 device, which is powered by our patented Kronos(R) air disinfection technology, represents a major step forward to marketing our products to hospitals, doctors’ offices, allergy suffers and areas where natural disasters occurred like when wildfires happen.”

To view the full press release, visit https://ibn.fm/p7ZcS

About Kronos Advanced Technologies Inc.

The company was initially founded in 2002 and funded by the U.S. military to develop electrostatic air movers. Eventually, the company moved into the consumer air purification business. It began operations as a product development company that invented and significantly changed the way air is moved, filtered and sterilized. Historically, Kronos has focused on developing, marketing and selling the company’s proprietary air movement and purification technology. Serving the indoor air quality (“IAQ”) market, Kronos technology uses state-of-the-art high-voltage patented processes without the use of traditional porous HEPA filters. Kronos-based products move air silently, filter, sterilize, and purify the air while dramatically reducing energy consumption to half of a 60-watt light bulb. Kronos devices can be variable in shape or size and, therefore, have the potential to be scaled down for air purification in cars or scaled up in size for industrial and hazardous gas destruction. The technology is currently being implemented in multiple standalone products for businesses, homes and vehicles of all types — to move, sterilize and filter air, including removing allergens down to 14.6 nanometers, passing through its patented technology — replacing expensive outdated passive HEPA and other filtration type systems. There are broad ranges of additional markets for standalone and embedded Kronos CORE technology-based devices. Examples of immediately addressable markets include schools, universities, health care facilities, operating rooms, manufacturing clean rooms, and the cabins of automobiles and commercial aircraft. For more information, visit the company’s website at www.KronosATI.co.

NOTE TO INVESTORS: The latest news and updates relating to KNOS are available in the company’s newsroom at https://ibn.fm/KNOS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing innovative treatments for patients suffering from dentofacial abnormalities and/or mild to moderate obstructive sleep apnea (OSA) and snoring in adults, has closed on its previously announced private placement. The placement was with a single institutional investor and resulted in approximately $8 million in gross proceeds. According to the release, the company will receive net proceeds of some $7.4 million after agent fees and estimated offering expenses are deducted. Vivos plans to use the private placement funds for general working capital and corporate purposes to support its efforts in driving revenue growth and managing expenses.

The private placement included 2 million shares of VVOS common stock, prefunded warrants to purchase up to 4,666,667 shares of company common stock and common stock purchase warrants to purchase up to 6,666,667 shares of company common stock at $1.20 per share.

To view the full press release, visit https://ibn.fm/MddfI

About Vivos Therapeutics Inc.

Vivos Therapeutics is a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as mild-to-moderate obstructive sleep apnea (“OSA”) as well as snoring in adults. The Vivos Method represents the first clinically effective, nonsurgical, noninvasive, nonpharmaceutical and cost-effective solution for treating mild to moderate OSA. It has proven effective in the treatment of more than 31,000 patients worldwide by more than 1,650 trained dentists. The Vivos Method includes the Vivos Complete Airway Repositioning and/or Expansion (“CARE”) appliance therapy and associated protocols that alter the size, shape and position of the tissues that comprise a patient’s upper airway and palate. The Vivos Method opens airway space and may significantly reduce symptoms and conditions associated with mild to moderate OSA, such as lowering Apnea Hypopnea Index scores. Vivos also markets and distributes SleepImage diagnostic technology under its VivoScore program for home sleep testing in adults and children. The Vivos Integrated Practice (“VIP”) program offers dentist training and other value-added services in connection with using the Vivos Method. For more information about this company, visit www.VivosLife.com.  

NOTE TO INVESTORS: The latest news and updates relating to VVOS are available in the company’s newsroom at http://ibn.fm/VVOS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

• Cannabis companies are regarded as being particularly vulnerable to cyberattacks, including potential ransomware incidents, because of their high cash-flow operations and their small business status, heightened by remote work due to Covid
• Cybersecurity services and technology provider SideChannel serves the needs of emerging businesses that may be hard-pressed to hire a full-time cybersecurity expert and need an affordable alternative
• SideChannel provides virtual chief information security officer (“vCISO”) services on a contract basis, drawing on a collective 450 years of experience

When the COVID-19 pandemic caused a wide array of industries to shut down their operations and then reopen with heightened emphasis on remote work, it created a generous opportunity for cyber criminals to exploit the increased business dependence on the Internet for core functions.

Chainalysis, a company that tracks digital transactions on the blockchain, reported ransomware payments from victims surged by 311 percent between 2019 and 2020 to reach nearly $350 million, for example. Ransomware is a cyberattack in which a target’s computer files are accessed and then…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

FE Battery Metals (CSE: FE) (OTCQB: FEMFD), a publicly traded Canadian mineral exploration company, has entered into an option and joint venture (“JV”) agreement with Infini Resources. The agreement outlines how Infini Resources could earn a 100% interest in 255 lithium claims located in Quebec. According to the announcement, FE Battery Metals holds more than 700 claims in the Abitibi region in Quebec; the company also plans to advance exploration efforts on the Augustus and Canada Lithium showings, which are directly adjacent to the NAL Mine currently owned by Sayona Mining Inc. The company anticipates sharing additional details regarding its 2023 exploration program at Augustus Lithium in the future. The announcement also noted that, based on the option agreement, Infini Resources has opted to earn an initial 50% interest by making an initial cash payment of AUD$550,000; once that option is exercised, a JV would be formed between FE Battery and Infini Resources to advance the project. “We are excited to enter into this option agreement with Infini Resources and look forward to exploring new areas of our large land package alongside Infini Resources,” said FE Battery Metals CEO and director Gurminder Sangha in the press release. “FE will continue to focus its exploration efforts on its core claim group with hosts the Augustus and Canada Lithium showings.”

To view the full press release, visit https://ibn.fm/ctliT

About FE Battery Metals Corp.

FE Battery Metals is a Canadian mineral exploration company with a primary focus of acquiring mineral properties in the battery metal sector. The company’s goal is to identify, acquire and explore North American mineral prospects with a primary focus on lithium. It’s strategy is to acquire and advance projects through prospecting and early-stage exploration; source joint venture partners to finance future exploration and project development; and create shareholder value through exploration success. For more information about the company, please visit www.FirstEnergyMetals.com.

NOTE TO INVESTORS: The latest news and updates relating to FEMFF are available in the company’s newsroom at https://ibn.fm/FEMFF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, has published new research in the peer-reviewed journal, “Applied Sciences,” as part of a special issue featuring digital therapeutics applications for chronic disease management. The research shows improved outcomes for users living with diabetes across different racial and ethnic groups. According to the announcement, disparities among racial and ethnic groups are common in many chronic conditions, including diabetes. The research evaluated retrospective data from 1,000 individuals diagnosed with type 2 diabetes who used Dario’s platform during a 12-month period. Data from users who identified as White was compared to the data of those identifying as Black, Latino or Asian. The article reported that the gathered data indicated no statistical difference in the levels of engagement across racial and ethnic groups as well as notable improvements in average blood glucose between the first and last month with no statistical difference between racial and ethnic groups. Specifically, the numbers show a 14% reduction in White users and a 15% reduction in Black, Latino and Asian users. “We are thrilled to expand our research on the important topic of digital health as a means to help address health inequities,” said Dario vice president of clinical and scientific affairs Yifat Hershcovitz, PhD, in the press release. “We serve a diverse user population and improving outcomes for everyone is always our goal. This new study provides assurance that our solutions have a positive clinical impact regardless of race or ethnicity.”

To view the full press release, visit https://ibn.fm/9NYdR

About DarioHealth Corp.

DarioHealth Corp. is a leading digital therapeutics (DTx) company revolutionizing how people with chronic conditions manage their health through a user-centric, multichronic condition platform. Dario’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health. The company’s user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention, and results. Dario provides its highly user rated solutions globally to health plans and other payors, self-insured employers, providers of care and directly to consumers. For more information about the company, please visit www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

PlantX Life (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1), the digital face of the plant-based community operating a one-stop shop for plant-based products, today announced preliminary and unaudited financial metrics for the third quarter of 2022, the period ended Dec. 31, 2022. “We continue to build a diversified platform for sustainable growth, leveraging our expanding presence in the plant-based ecosystem and greater cross-promotional capabilities,” said PlantX CEO Lorne Rapkin. “Recent acquisitions of Little West and EH & Portfolio Coffee are playing key roles in our growth, and our New Deli and PlantX Living expansions are contributing to revenue diversification and market awareness. Geographically, our expansion to the U.K. and Israel have been successful, and we are growing our presence in these important regions. As we enter 2023, we believe this will be a year of continued growth for PlantX.”

To view the full press release, visit https://ibn.fm/K0vhu

About PlantX Life Inc.

As the digital face of the plant-based community, PlantX’s platform is the one-stop shop for everything plant-based. With its fast-growing category verticals, the company offers customers across North America more than 5,000 plant-based products. In addition to offering delivery service for meals and indoor plants, the company currently has plans underway to expand its product lines to include a juice and coffee company. PlantX uses its digital platform to build a community of likeminded consumers and, most importantly, to provide education. Its successful enterprise is being built and fortified on partnerships with the top nutritionists, chefs and brands. The company’s digital presence works to eliminate the barriers to entry for anyone interested in living a plant-based lifestyle and thriving in a longer, healthier and happier life. For more information, visit the company’s investor website at https://Investor.PlantX.com.

NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Siyata Mobile (NASDAQ: SYTA, SYTAW), a global vendor of push-to-talk over cellular (“PoC”) devices and cellular signal booster systems, today announced that T-Mobile US Inc. (NASDAQ: TMUS), the second largest wireless carrier in the U.S. with more than 111.7 million customers*, will launch Siyata’s rugged SD7 device onto its Internet of Things (“IoT”) data network. T-Mobile is expected to begin selling the SD7, developed to disrupt and replace the multibillion land mobile radio (“LMR”) industry, to the company’s broad enterprise customer base beginning in the first quarter of 2023. “With the addition of T-Mobile, we are significantly expanding our addressable market and entering 2023 in a strong position with all major U.S. wireless carriers now offering SD7 as well as additional partnerships internationally,” said Siyata CEO Marc Seelenfreund. “This relationship with T-Mobile strengthens our network compatibility and further expands our ability to reach first responders and enterprise personnel with a reliable PoC device that can operate extremely well in tough working environments.”

To view the full press release, visit https://ibn.fm/TtPOD

About Siyata Mobile Inc.

Siyata Mobile is a B2B global vendor of next-generation push-to-talk over cellular (“PoC”) devices and cellular booster systems. Its in-vehicle and rugged smartphones enable first responders and enterprise workers to instantly communicate, over a nationwide cellular network of choice, to increase situational awareness and save lives. Its portfolio of enterprise grade and consumer cellular booster systems enables first responders and enterprise workers to amplify cellular signal in remote areas, inside structural buildings where signals are weak and within vehicles for the maximum cellular signal strength possible. Siyata’s common shares trade on the Nasdaq under the symbol SYTA and its previously issued warrants trade on the Nasdaq under the symbol SYTAW. For more information about the company, visit www.SiyataMobile.com and UnidenCellular.com.

*https://pr.report/plohIcG0

NOTE TO INVESTORS: The latest news and updates relating to SYTA are available in the company’s newsroom at https://ibn.fm/SYTA

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Prime Harvest, a legal cannabis company focused on tech and parent company to Jaxx Cannabis, was part of an appeal process heard by the Southeastern San Diego Planning Group. In a neighborhood that has shown a “nearly united front” against cannabis outlets that aren’t focused on social equity and neighborhood enrichment, the 8-to-2 vote to approve a conditional use permit process (“CUP”) for Prime Harvest showed public support for the entity. An article, titled “What a Difference a Year Makes — Mt. Hope Gets the Cannabis Outlet They Want,” reports on the successful efforts that the city and county are making to work on social equity programs that address inequality in the cannabis industry. The article noted that, prior to the hearing, Prime Harvest D9 had held multiple meetings with all concerned parties and integrated the needs of the community into its project. Consequently, neighborhood groups showed up at both the public hearing and appeal hearing in support of the company. “At appeal hearings, the public fills out forms marked that they ‘Oppose’ the appeal or are ‘In-Favor’ of the appeal,” the article reported. “Sharon Whitehurst-Payne, who represents southeastern (DE) San Diego on the Board of Education stood at the podium to remind us of neighborhood neglect and say that she would not oppose and may support the Gateway project should they do what they have offered. Quite a few community members spoke, quite a few more turned in slips that they opposed the appeal [against Prime Harvest], but they didn’t speak.  The slip ratio was dozens to one. Not typical which is why this is so interesting.”

To view the full press release, visit https://ibn.fm/zTfo6

About Prime Harvest Inc.

Prime Harvest is a technology-focused, full-service cannabis corporation. The company is horizontally diversified across various segments of the cannabis value chain, including licensing acquisition and compliance management, and statewide direct-to-consumer operations. Based in the innovation hot spot of San Diego, California, Prime Harvest is expanding its footprint throughout the Golden State by executing a long-term strategy of investing in the growth and scale of licensed assets anchored by the power of data-driven technology. Prime Harvest’s flagship retail brand, Jaxx Cannabis, upholds exceptional standards of quality and services and provides a rewarding experience for customers in San Diego and the surrounding Southern California communities. Trust and credibility are at the heart of everything that the team at Prime Harvest stands for. The Prime Harvest team is composed of true experts in their respective fields, carefully assembled with the aim of building a world-class organization that can drive the cannabis industry and movement forward. For more information about the company, visit www.PrimeHarvestInc.com.

NOTE TO INVESTORS: The latest news and updates relating to Prime are available in the company’s newsroom at https://ibn.fm/PRIME

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Nutriband (NASDAQ: NTRB), a pioneer in the science of using novel transdermal solutions and other innovative technologies, has kicked off the new by becoming the first NASDAQ company to dual list digital shares on Upstream, a fully regulated global stock exchange for digital securities and NFTs. The company began trading on Upstream yesterday under the ticker symbol NTRB. According to the announcement, the dual listing is designed to provide Nutriband with access to a global, digital-first investor base; potential investors will be able to trade using USDC digital currency as well as credit, debit, PayPal and USD, which will unlock liquidity, enhance price discovery and globalize the opportunity to invest in the company. “We are proud to have a trailblazer like Nutriband as the first company to dual list on Upstream and offer its shares to an international investor base seeking streamlined access to U.S. companies,” said Upstream cofounder Mark Elenowitz in the press release.

To view the full press release, visit https://ibn.fm/HO8TB

About Nutriband Inc.

Nutriband is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. The company’s lead product under development is an abuse deterrent fentanyl patch incorporating its AVERSA(TM) abuse deterrence technology. AVERSA technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion and accidental exposure of drugs with abuse potential. For more information about the company, please visit www.Nutriband.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Universal Ibogaine (TSX.V: IBO) (“UI”), a life sciences company with a mission to transform the addiction treatment industry with medicalized ibogaine-centered care, today provided a year-end summary of 2022 accomplishments. “2022 was a busy year of behind-the-scenes activity laying the foundations with Health Canada in preparation for the planned clinical trial application and sourcing the related ibogaine drug supply,” said Nick Karos, chief executive officer and board member of Universal Ibogaine. “We are finalizing discussions with several potential funding partners and intend on closing the second round of our current convertible debt financing very shortly. 2023 will be a pivotal year for our company, for our shareholders and for Canadians who are actively seeking ibogaine treatment.”

To view the full press release, visit https://ibn.fm/dvjpV

About Universal Ibogaine Inc. (“UI”)

UI is a life sciences company with a mission to transform addiction treatment using medicalized ibogaine through a planned Canadian clinical trial focused on opioid use disorder, and ultimately to utilize that protocol globally through planned future licensing agreements. UI is concurrently developing a state-of-the-art holistic addiction treatment protocol at its Kelburn Recovery Centre that, which when paired with the planned ibogaine detox protocol, is intended to revolutionize the way we treat addiction and drastically improve the lives of individuals and families affected by addiction. For more information about the company, visit https://universalibogaine.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

D-Wave (NYSE: QBTS), a leader in quantum computing systems, software and services and the world’s first commercial supplier of quantum computers, and Davidson Technologies Inc., a technology services company that provides innovative engineering, technical and management solutions for the Department of Defense, aerospace and commercial customers, today announced the companies’ entry into a multi-year reseller agreement. At its upcoming annual user conference, Qubits, D-Wave will highlight the new alliance, which enables Davidson to resell D-Wave’s products and services, including the Leap(TM) quantum cloud service. The companies are also collaborating on an initiative to support classified quantum-hybrid applications, an important requirement for national defense programs.

“Davidson has a reputation for recognizing how emerging and advanced technologies can be applied to help customers navigate change, embrace risks and grow,” said Dr. Alan Baratz, CEO of D-Wave. “We share that spirit of imagining the unimaginable and harnessing the power of technology in service to our customers. Through our collaboration, we’re extending Davidson’s impressive portfolio with annealing quantum computing solutions designed to tackle government customers’ increasingly complex computational problems, today.”

To view the full press release, visit https://ibn.fm/2ogtX

About D-Wave Quantum Inc.

D-Wave is a leader in the development and delivery of quantum computing systems, software and services, and is the world’s first commercial supplier of quantum computers — and the only company building both annealing quantum computers and gate-model quantum computers. The company’s mission is to unlock the power of quantum computing today to benefit business and society. D-Wave does this by delivering customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection and financial modeling. D-Wave’s technology is being used by some of the world’s most advanced organizations, including NEC Corporation, Volkswagen, DENSO, Lockheed Martin, Forschungszentrum Jülich, University of Southern California, and Los Alamos National Laboratory. For more information about the company, visit www.DWaveSys.com.

NOTE TO INVESTORS: The latest news and updates relating to QBTS are available in the company’s newsroom at https://ibn.fm/QBTS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

SideChannel (OTCQB: SDCH) CEO Brian Haugli is one of several cybersecurity experts quoted in a recent “Information Week” article outlining five questions to ask about protecting a business. The article mentioned a widespread phishing campaign that took place last August against customer-engagement platform Twilio and content-delivery network Cloudflare. The cyberattack stole nearly 10,000 sets of credentials, with the tally rising much higher if downstream customers that were impacted were included in the count. Haugli addressed the fact that even if a company “has a firm grasp of IAM within their own four walls, risk extends much further. The Twilio supply chain attack had hundreds of secondary victims.” He noted that understanding where vendors are actually being used in the ecosystem beyond “your own four walls” becomes very important for security. “Understanding where your vendors are actually being used, not just for yourself but in a greater ecosystem, becomes very important for your own security,” said SideChannel founder and CEO Brian Haugli in the press release. “Because somebody else’s mishap now becomes your problem. I don’t think we do enough building programs based on standards and recognized frameworks.”

To view the full article, visit https://ibn.fm/X5qhQ

About SideChannel Inc.

SideChannel is committed to creating top-tier cybersecurity programs for mid-market companies to help them protect their assets. SideChannel employs what it believes to be skilled and experienced talent to harden these companies’ defenses against cybercrime, in its many forms. SideChannel’s team of C-suite level information security officers possess a combined experience of more than 400 years in the industry. To date, SideChannel has created more than 50 multilayered cybersecurity programs for its clients. For more information about the company, please visit www.SideChannel.com. 

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Nutriband (NASDAQ: NTRB), a pioneer in the science of using novel transdermal solutions and other innovative technologies, has announced that it has commenced trading on Upstream, a MERJ Exchange Market that is a fully regulated global stock exchange for digital securities and NFTs. The company, which began trading on Upstream today using the NTRB ticker symbol, is among the first issuers to dual list on the market. The company released a digital collectible NFT commemorating the dual listing, which is available for all Upstream participants to claim with a claim code: NTRB! “We are thrilled to be amongst the first companies to dual list on Upstream’s next generation marketplace,” said Nutriband CEO Gareth Sheridan in the press release. “We are adding new value to our shareholders while expanding our company and mission to a modern, global investor-base.”

To view the full press release, visit https://ibn.fm/9tMVN

About Nutriband Inc.

Nutriband is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. The company’s lead product under development is an abuse deterrent fentanyl patch incorporating its AVERSA(TM) abuse deterrence technology. AVERSA technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion and accidental exposure of drugs with abuse potential. For more information about the company, please visit www.Nutriband.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

180 Life Sciences (NASDAQ: ATNF), a clinical-stage biotechnology company, has regained full compliance with NASDAQ minimum-bid price requirements. The company received a letter from the NASDAQ Stock Market LLC providing notification of the change in status; the letter was dated Jan. 4, 2023. According to the letter, the exchange determined that the closing bid price of the company’s common stock was at or above $1 per share for 10 consecutive business days, which is the minimum requirement. Therefore, ATNF has regained compliance.

To view the full press release, visit https://ibn.fm/P9tkR

About 180 Life Sciences Corp.

180 Life Sciences is a clinical-stage biotechnology company driving groundbreaking studies into clinical programs that are seeking to address major unmet medical needs. The company’s focus is a novel program to treat several inflammatory disorders using anti-TNF (tumor necrosis factor). For more information about the company, visit www.180LifeSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to ATNF are available in the company’s newsroom at https://ibn.fm/ATNF 

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing innovative treatments for patients suffering from dentofacial abnormalities and/or mild to moderate obstructive sleep apnea (OSA) and snoring in adults, has entered into a definitive agreement. According to the announcement, the agreement is with a single institutional investor and is estimated to raise $8 million through a private placement offering with a single unit price $1.20. The offering defined each unit as one share of common stock (or a prefunded warrant to purchase one share of common stock) and one warrant exercisable for one share common stock at a price of $1.20 per share for a period of five years and 6 months from closing. The announced noted that no actual units will be issued in the offering. “After the placement agent fees and estimated offering expenses payable by the company, the company expects to receive net proceeds of approximately $7.5 million,” the announcement stated. “The offering is expected to close on Jan. 9, 2023, subject to customary closing conditions.”

To view the full press release, visit https://ibn.fm/4KDkx

About Vivos Therapeutics Inc.

Vivos Therapeutics is a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as mild-to-moderate obstructive sleep apnea (“OSA”) as well as snoring in adults. The Vivos Method represents the first clinically effective, nonsurgical, noninvasive, nonpharmaceutical and cost-effective solution for treating mild to moderate OSA. It has proven effective in the treatment of more than 31,000 patients worldwide by more than 1,650 trained dentists. The Vivos Method includes the Vivos Complete Airway Repositioning and/or Expansion (“CARE”) appliance therapy and associated protocols that alter the size, shape and position of the soft tissues that comprise a patient’s upper airway and palate. The Vivos Method opens airway space and may significantly reduce symptoms and conditions associated with mild to moderate OSA, such as lowering Apnea Hypopnea Index scores. Vivos also markets and distributes SleepImage diagnostic technology under its VivoScore program for home sleep testing in adults and children. The Vivos Integrated Practice (“VIP”) program offers dentist training and other value-added services in connection with using the Vivos Method. For more information about this company, visit www.VivosLife.com.  

NOTE TO INVESTORS: The latest news and updates relating to VVOS are available in the company’s newsroom at http://ibn.fm/VVOS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Splash Beverage Group (NYSE American: SBEV), a portfolio company of leading beverage brands, today issued a letter to shareholders from Robert Nistico, SBEV’s CEO and chairman. “As we embark upon 2023, I wanted to take this opportunity to briefly update our shareholders on some key developments that have taken place at Splash Beverage Group since our last corporate update. Since our August update, we have continued to add distribution agreements and retail authorizations. This is a result of positive brand performance in existing accounts, and our growing reputation in the industry. Keep in mind that each new distributor and / or retail chain adds revenue for Splash,” Nistico stated in the letter, further detailing the company’s expansions and growth. “Each of our brands tap into unique trends in consumer preferences, and we believe that we are in the right categories at the right time. We are very grateful to have you as shareholders and we look forward to continuing to earn that confidence.”

To view the full press release, visit https://ibn.fm/ZIP8D

About Splash Beverage Group Inc.

Splash Beverage Group, an innovator in the beverage industry, owns a growing portfolio of alcoholic and non-alcoholic beverage brands including Copa di Vino wine by the glass, SALT flavored tequilas, Pulpoloco sangria, and TapouT performance hydration and recovery drink. Splash’s strategy is to rapidly develop early stage brands already in its portfolio as well as acquire and then accelerate brands that have high visibility or are innovators in their categories. Led by a management team that has built and managed some of the top brands in the beverage industry and led sales from product launch into the billions, Splash is rapidly expanding its brand portfolio and global distribution. For more information about the company, visit www.SplashBeverageGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to SBEV are available in the company’s newsroom at https://ibn.fm/SBEV

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a clinical-stage biotechnology company focused on developing intravenous-infused psilocin (the active metabolite of psilocybin) for diseases with high unmet medical needs, today announced interim results for the first five patients dosed in its Phase II STOP (Study of the Treatment of Overeating utilizing Psilocybin) trial. In collaboration with the University of Florida, the trial is evaluating TRP-8802 (oral psilocybin) in patients with binge eating disorder (“BED”) and represents the first use of psilocybin in conjunction with psychotherapy as a therapeutic intervention in patients with BED. “The magnitude and consistency of the trends observed in this interim analysis are incredibly encouraging,” said Tryp’s CEO Jim Gilligan, Ph.D. “Furthermore, these preliminary results provide us with the confidence that BED is a viable target for future studies with psychedelic-assisted psychotherapy utilizing TRP-8803, our proprietary IV formulation of psilocin that alleviates numerous shortcomings of oral psilocybin including: significantly reducing the time to onset of the psychedelic state, controlling the depth and duration of the psychedelic experience, and reducing the overall duration of the intervention to a commercially feasible timeframe. Our strategy is to perform small exploratory studies using TRP-8802 for unique indications including BED, fibromyalgia and irritable bowel syndrome, all in partnership with leading academic institutions. Once a positive clinical signal is identified in studies using TRP-8802, we intend to perform subsequent studies with TRP-8803.”

To view the full press release, visit https://ibn.fm/uKc7s

About Tryp Therapeutics Inc.

Tryp Therapeutics is a clinical-stage biotechnology company focused on developing proprietary, novel formulations for the administration of psilocin in combination with psychotherapy to treat diseases with unmet medical needs. Tryp’s lead program, TRP-8803, is a proprietary formulation of IV-infused psilocin (the active metabolite of psilocybin) that alleviates numerous shortcomings of oral psilocybin including: significantly reducing the time to onset of the psychedelic state, controlling the depth and duration of the psychedelic experience, and reducing the overall duration of the intervention to a commercially feasible timeframe. The company has an ongoing phase 2a clinical trial for the treatment of binge eating disorder at the University of Florida and an upcoming phase 2a clinical trial with the University of Michigan for the treatment of fibromyalgia, both of which are utilizing TRP-8802 (synthetic, oral psilocybin) to demonstrate efficacy in these indications. Where a preliminary clinical benefit has been demonstrated, subsequent studies are expected to utilize TRP-8803, which has the potential to further improve efficacy, safety and patient experience. For more information about the company, please visit www.TrypTherapeutics.com.

NOTE TO INVESTORS: The latest news and updates relating to TRYPF are available in the company’s newsroom at https://ibn.fm/TRYPF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

SideChannel (OTCQB: SDCH) was featured in a recent “Cyber for Hire – The Managed Security Podcast” published by SC Media. The piece delves into factors to consider when paring a company with a fractional or virtual CISO, looking at how to find a harmonious match. SideChannel’s founder and CEO Brian Haugli joined program co-hosts Bradley Barth and Ryan Morris to discuss the facets that go into the role or service to successfully make the solution work for a client long term. “I’ve been across the whole spectrum… Starting and building the company that I’m in, SideChannel, I started out as a solo practitioner. So, I’ve lived that life and figured that out, now scaling it to offer many different CISOs to many different clients,” Haugli said, discussing what he has learned, now seeing the whole gamut of how to make the connection work between personalities and backgrounds. “Geography is actually a big deal, and it’s mostly for the service provider/vCISO,” he said, discussing the need for providers to consider compatibility and adjustments required when working with a client on the east vs. west coast or their various location. “Expertise… that’s probably the largest component,” Haugli further explained, sharing insight on the key requirement for the CISO to serve the clients they are working with.

To view the full podcast, visit https://ibn.fm/vAbfs

About SideChannel Inc.

SideChannel is committed to creating top-tier cybersecurity programs for mid-market companies to help them protect their assets. SideChannel employs what it believes to be skilled and experienced talent to harden these companies’ defenses against cybercrime, in its many forms. SideChannel’s team of C-suite level information security officers possess a combined experience of over 400 years in the industry. To date, SideChannel has created more than 50 multilayered cybersecurity programs for its clients. For more information about the company, visit SideChannel.com.

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.